Gene Query: RBM7

Dataset Description Geneva Score
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 44.72
38.83
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 28.88
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 16.83
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 15.68
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 15.56
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 15.07
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 13.88
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 13.63
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 13.48
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 13.48
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 12.63
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 12.28
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 12.01
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 11.83
HNF1 regulates critical functions of the human epididymis epithelium. 11.83
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.73
Survival of pancreatic cancer cells lacking KRAS function 11.46
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 11.29
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 11.1
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 10.97
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.92
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 10.9
Transcriptome analysis in Neobractatin treated cells 10.89
Transcriptome of diurnal human blood neutrophils 10.72
Functional role of SLIT2 and ROBO1 in trophoblasts 10.08
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 10.02
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 9.88
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.77
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.77
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 9.64
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.27
Gene expression in PANC1 cells treated with Rakicidin 9.12
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.01
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.01
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 8.93
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.91
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.91
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.89
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 8.65
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 8.43
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 8.22
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.14
Functional role of CPPED1 in trophoblasts. 7.98
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 7.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.85
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.85
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 7.72
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.63
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.63
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.52
Regulation of Lipids is Central to Replicative Senescence 7.49
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.45
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.82
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.72
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.72
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.61
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.58
EGR1-controlled transcriptome of T HESCs 6.44
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 6.43
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 6.41
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.38
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.33
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 6.3
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 6.3
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.28
DART-seq: an antibody-free method for global m6A detection 6.23
Dtx3L and Androgen Signaling in Prostate Cancer 6.2
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 6.19
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.06
Genome wide expression change by RNF168 knocking down in NEC cells 5.99
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.93
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.86
R430: A potent inbibitor of DNA and RNA viruses 5.67
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.65
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.63
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.41
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 5.4
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 5.4
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.4
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.4
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.38
DRB/GRO-Seq -/+ UV 5.37
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.33
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 5.31
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 5.29
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 5.28
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.22
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.22
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.19
Primary human trophoblast from term placenta 5.19
Transcriptional profile in human S. haematobium infection 5.14
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.14
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 5.08
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.05
CROP-Seq in Primary Human T Cells 5.03
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.95
Single-cell analysis of human kidney organoids 4.94
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 4.89
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 4.87
Tracking of dCas9-methyltransferase footprints 4.86
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 4.83
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.82
RNA expression analysis upon JMJD1C depletion 4.82
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 4.74
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 4.73
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 4.73
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.67
ARID1A regulates condensin II distribution and chromosomal partition 4.67
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.64
RNA seq comparison between scrambled and shGRP78 cells 4.61
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.59
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.59
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.57
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 4.51
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.5
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 4.49
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.48
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 4.46
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.46
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.44
Effect of mitochondria deficiency on senescence-associated gene expression 4.44
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.44
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.44
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.43
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.41
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.36
SRSF2 mutations impair hematopoiesis and alter exon recognition 4.34
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 4.3
Human Treg NaCl stimulation 4.29
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.21
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 4.2
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.2
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 4.18
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.16
Accurate annotation of human protein-coding small open reading frames 4.15
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.13
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.11
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.03
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.03
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.03
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 4.01
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.95
SNHG5 siRNA knock down in HCT116 cells 3.95
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.89
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 3.89
Transcriptome of U251 cells overexpression complement component 7 3.89
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.87
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.84
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.84
Expression profiling of etoposide-induced senescent cells 3.84
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.83
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.79
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.77
The evolution of N6-methyladenosine in primates 3.75
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.75
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 3.74
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.71
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.71
RNA-Sequencing of HepG2 cells treated with TGFBeta 3.71
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.71
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.67
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.67
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.66
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 3.66
Differetially expressed genes after hTR overexpression in U2OS cells 3.66
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.65
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.64
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 3.64
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 3.64
KSDM1b Role in Ewing Sarcoma 3.63
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 3.62
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.62
SLAM-seq for K562 endogenous mRNA decay 3.61
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.57
RNA-seq analyses of human prostate cancer cells 3.57
mRNA expression profile of Lymphocytes 3.57
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 3.55
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.54
Noncoding regions are the main source of targetable tumor-specific antigens 3.54
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 3.53
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.53
Effect of drugs on transcriptomic profiles 3.5
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.5
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 3.49
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.45
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.44
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.44
Trans-differentiation of human adult peripheral blood T cells into neurons 3.44
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.44
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 3.41
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.39
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.38
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.38
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.37
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.35
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.34
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.34
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.33
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.33
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.3
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 3.28
PRDM1 inhibits proliferation of human colon cancer organoids 3.28
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.24
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.24
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.24
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.24
Role of COP1 on MAP kinase transcriptional output in melanoma 3.22
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.17
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 3.15
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.14
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.13
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 3.12
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.12
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 3.11
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.09
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.07
Overexpression and knockdown experiment for circCSNK1G3 3.06
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.02
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.02
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.02
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 2.98
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.98
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 2.96
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 2.96
Identification of renal resident macrophages across species 2.96
IRF2 is a master regulator of human keratinocyte stem cell fate 2.95
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.95
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.94
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.94
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.93
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.93
Molecular Criteria for Defining the Naive Human Pluripotent State 2.89
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.88
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.87
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.86
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.85
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.81
RNA-Seq from human ILC transitional populations 2.81
The Genetic Landscape of Diamond-Blackfan Anemia 2.8
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.78
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.77
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.77
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.77
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.76
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.72
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.72
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.72
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 2.7
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 2.7
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.69
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.68
CD73 knockdown effect in pancreatic cancer cell lines 2.68
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.67
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.66
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.66
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 2.65
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 2.63
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 2.59
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.58
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.57
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.57
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.55
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.54
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.53
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 2.51
Endothelial gene expression analysis 2.51
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.5
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.5
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.5
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.5
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.48
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.45
Illumina Total RNA-seq in HeLa 2.44
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.43
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.43
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.43
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.41
STX4 Over-Expression in Human islets 2.4
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.38
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 2.37
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.37
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.37
Global analysis of enhancer targets: Mosaic-seq 2.35
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.34
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.31
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.31
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.29
RNA-seq of naive and primed ES cells 2.28
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 2.27
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.27
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.25
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.23
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.22
scRNASeq analysis of cycling cardiomyocytes 2.2
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.2
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 2.17
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.13
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.11
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.1
HBEC-shp53-PCHD7 2.09
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.07
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.07
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.06
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.97
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.96
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.94
Functional significance of the HIV-1 Tat signature amino acid residues 1.9
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.89
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.88
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.87
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.85
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.83
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.82
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.81
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.8
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.79
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.73
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.71
Identification of renal resident macrophages across species [C1] 1.7
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 1.68
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 1.68
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.67
Sensing self and nonself circular RNAs 1.67
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.65
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 1.63
Polarized B -cell functions 1.61
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.59
IMP3 regulated gene expression in breast cancer cells 1.59
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.55
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.55
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 1.55
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.55
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.54
Direct Isolation and Characterization of Human Nephron Progenitors. 1.54
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.54
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.54
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.52
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.52
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 1.51
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.51
Expression level comparison under dividing and quiescent states in human primary fibroblasts 1.5
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.49
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.47
Human Treg IL-12 stimulation 1.47
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.46
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.43
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.43
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.42
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.42
Gene expression signatures of innate lymphoid cells from human blood 1.41
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.41
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.37
Effect of PRDM11 depletion in U2932 cells 1.37
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.34
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.34
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.34
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.33
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.31
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.29
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.29
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.28
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.26
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.24
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.23
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.23
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.23
Transcriptional landscape changes during human embryonic stem cell derivation 1.22
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.21
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.2
Regulation of hypoxia-inducible factor activity by ZMYND8 1.19
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.18
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.17
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.17
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.17
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.17
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.16
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.14
Regulation of protein translation during mitosis 1.13
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.12
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.1
Dermal endothelial cells of type 2 diabetic patients 1.1
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.06
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.06
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.04
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.03
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.01
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.0
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.99
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.98
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.98
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.98
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.98
TT-Seq captures the human transient transcriptome 0.97
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 0.96
K562 polyA RNA-Seq 0.96
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.95
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.92
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.91
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.9
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.9
Investigate A2M treatment on human prostate cancer xenograft in mice 0.9
Investigate A2M treatment on human prostate cancer and mouse liver 0.9
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 0.89
Identification of a LIF-responsive replication-competent human β cell 0.88
6mer seed toxicity in viral microRNAs 0.87
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.87
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.86
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.85
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.81
Discovering human diabetes-risk gene function with genetics and physiological assays 0.81
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.8
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.79
MAIT cell RNA sequencing 0.78
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.78
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.78
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.78
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.77
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.77
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.77
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.76
hNSCs siRNA NOVA2 0.76
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.75
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 0.75
RNA-Seq of PRMT1 overexpression ECA109 cells 0.74
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.72
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.7
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.69
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.67
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.66
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.65
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 0.63
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.59
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.59
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.59
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.56
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.55
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.53
Copper Regulation of HIF-1 Transcription Activity 0.52
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.52
Specific molecular signatures underlie response to decitabine in CMML 0.5
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.5
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.49
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.47
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.47
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.44
FOXP1 orchestration of ASD-relevant signaling pathways. 0.43
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.42
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.41
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.4
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.4
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.4
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.39
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.37
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.36
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.35
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.34
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.34
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.33
Function and hormonal regulation of GATA3 in human first trimester placentation 0.33
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.32
RNA-seq analysis upon ARID1B overexpression 0.31
RNA-seq of primary patient AML samples 0.3
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 0.29
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 0.29
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.29
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.29
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.27
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.26
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.26
Unique features and clinical importance of acute alloreactive immune responses 0.23
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.21
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.21
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.2
RNA-seq data 0.19
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.19
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.19
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.18
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.16
RNA seq analysis of human Fetal and adult derived Enterospheres 0.15
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.13
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.13
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.12
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.11
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.1
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.08
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.08
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.07
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.06
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.06
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.04
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation